Jammu Tawi, Jan. 2 -- Amrita Hospital, Faridabad, in collaboration with ImmunoACT which is an IIT-Bombay incubated company, has introduced CAR T-cell (Chimeric antigen receptor) therapy for certain cancer patients, which is considered a significant breakthrough in B cell lymphoma and leukemia treatment, with promising results in relapsed and refractory patients. Four patients of B-cell Lymphoma have already undergone or are undergoing this therapy at Amrita Hospital so far and they are under follow-up.Dr. Prashant Mehta, Senior Consultant, Program Director (Lymphoid neoplasms & Cellular Therapy), Dept. of Medical Oncology / Hematoncology / BMT, Amrita Hospital, Faridabad said, "The treatment of cancer has improved immensely in the last fe...